John M. Maraganore
2020
Compensation breakdown
| Non-Equity Incentive Plan | $1,110,000 |
|---|---|
| Option Awards | $5,746,295 |
| Salary | $946,200 |
| Other | $15,669 |
| Total | $7,818,164 |
Maraganore received $5.7M in option awards, accounting for 73% of the total pay in 2020.
Maraganore also received $1.1M in non-equity incentive plan, $946.2K in salary and $15.7K in other compensation.
Rankings
In 2020, John M. Maraganore's compensation ranked 1,197th out of 13,090 executives tracked by ExecPay. In other words, Maraganore earned more than 90.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,197 out of 13,090 | 91st |
Division Manufacturing | 422 out of 5,624 | 93rd |
Major group Chemicals And Allied Products | 145 out of 2,257 | 94th |
Industry group Drugs | 125 out of 1,957 | 94th |
Industry Pharmaceutical Preparations | 93 out of 1,462 | 94th |
Pay ratio
| John M. Maraganore's Pay | $7,818,164 |
|---|---|
| Median Employee's Pay | $233,341 |
| Pay Ratio | 34to 1 |
In 2020, the annual total compensation of John M. Maraganore was $7,818,164.
The annual total compensation of the median employee at Alnylam Pharmaceuticals was $233,341.
The ratio of John M. Maraganore's pay to the pay of median employee was therefore 34 to one.
Maraganore's colleagues
We found five more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2020.
2020
Barry Greene
Alnylam Pharmaceuticals
Former President
2020
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2020
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2020
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
2020
Laurie Keating
Alnylam Pharmaceuticals